Metraipolis › archive › dc_a8b59e803e4d
Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study — Europe PMC PMID:40820125
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40820125
- DOI
- 10.1186/s12879-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T13:49:59.658Z
- SHA-256 of the archived text
5c296158af640978a759918dbf5666a2b981d1ef72293724022e2a87835d2a97- Stable URL of this page
https://metraipolis.com/documento/dc_a8b59e803e4d
How to cite
Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study — Europe PMC PMID:40820125 — Europe PMC (en), https://europepmc.org/article/MED/40820125 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a8b59e803e4d (Metraipolis archive dc_a8b59e803e4d, sha256 5c296158af640978a759918dbf5666a2b981d1ef72293724022e2a87835d2a97)
BibTeX
@misc{dca8b59e803e4d,
title = {Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study — Europe PMC PMID:40820125},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40820125},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a8b59e803e4d; sha256 5c296158af640978a759918dbf5666a2b981d1ef72293724022e2a87835d2a97},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40820125. Agents can read the archived copy with the MCP tool read_document.